Where We Are Headed - New Outlook on Forest Laboratories, Inc.

Where We Are Headed - New Outlook on Forest Laboratories, Inc. and Teva Pharmaceutical Industries Limited  JAKARTA, INDONESIA -- (Marketwire) -- 09/26/12 --  Moments ago, NationalTradersAssociation.org introduced new coverage of Forest Laboratories, Inc. (NYSE: FRX) and Teva Pharmaceutical Industries Limited (NYSE: TEVA). Full outlook, analysis and consensus opinion is available to readers via the links below.  www.NationalTradersAssociation.org/r/gov/1e1e_FRX  www.NationalTradersAssociation.org/r/gov/42ce_TEVA  The consistent delivery of accurate analyses relies solely on two factors, namely: market awareness and industry insight. Recent market drivers include August's existing home sales increasing more than expected within the U.S., a surprise slip in U.S. initial jobless claims in the week ending September 15, 2012 and the spark of U.S. housing starts over the last month. When it comes to discovering the right edge at the right time, all these factors play into effect. For a deeper understanding of the mechanics behind these events and how it can affect your portfolio, please refer to our email newsletter delivered to your inbox.  National Traders Association is releasing new coverage on Forest Laboratories, Inc. for its current position within the consumer durables sector. Forest Laboratories, Inc. (Forest) develops, manufactures and sells branded forms of ethical drug products, most of which requires a physician's prescription. The Company also focuses on the development and introduction of new products, including products developed in collaboration with licensing partners. A copy of this report featuring Forest Laboratories, Inc. (NYSE: FRX) is available at: www.NationalTradersAssociation.org/r/gov/1e1e_FRX.  National Traders Association has released research on Teva Pharmaceutical Industries Limited for its changing role within the consumer durables sector. Teva Pharmaceutical Industries Ltd (Teva) is a global pharmaceutical and drug company. It develops, produces and markets generic drugs in all treatment categories. The Company has a pharmaceutical business, whose principal products include Copaxone and Azilect. To access the full research report on Teva Pharmaceutical Industries Limited (NYSE: TEVA) we welcome investors to visit: www.NationalTradersAssociation.org/r/gov/42ce_TEVA.  Consider National Traders Association  Tired of hearing about the latest, greatest trade opportunity... only to realize that the ship has long sailed? You need a strong, informative community in your arsenal. Join the group that has been consistently identifying momentous situations as they develop -- long before they become the next top news on major financial networks.  Contact:  Demi Lapierre press@NationalTradersAssociation.org www.NationalTradersAssociation.org